Diagnostic and prognostic factors in patients with prostate cancer

被引：0

作者：

Beyer, K. ^{[1
]}

Moris, L. ^{[2
]}

Lardas, M. ^{[3
]}

Haire, A. ^{[1
]}

Barletta, F. ^{[4
]}

Scuderi, S. ^{[4
]}

Molnar, M. ^{[5
]}

Herrera, R. ^{[5
]}

Rauf, A. ^{[6
]}

Campi, R. ^{[7
]}

Greco, I. ^{[7
]}

Shiranov, K. ^{[8
]}

Dabestani, S. ^{[9
]}

Van den Broeck, T. ^{[2
]}

Gacci, M. ^{[7
]}

Gandaglia, G. ^{[4
]}

Omar, M. I. ^{[10
]}

Maclennan, S. ^{[10
]}

Roobol, M. J. ^{[11
]}

Zong, J. ^{[12
]}

Maclennan, S. J. ^{[10
]}

Collette, L. ^{[13
]}

Briganti, A. ^{[14
]}

Bjartell, A. ^{[15
]}

Van Hemelrijck, M. ^{[1
]}

机构：

[1] Kings Coll London, Translat & Oncol Res TOUR, London, England

[2] Univ Hosp Leuven, Dept Urol, Leuven, Belgium

[3] Metropolitan Gen, Dept Urol, Athens, Greece

[4] IRCCS Osped San Raffaele, Unit Urol, Div Oncol, URI, Milan, Italy

[5] Bayer AG, Dept Epidemiol, Berlin, Germany

[6] NHS Fdn Trust, Mid Cheshire Hosp, Dept Urol, Crewe, England

[7] Univ Florence, Dept Minimally Invas & Robot Urol Surg & Kidney T, Florence, Italy

[8] Zdorovie, CDC, Rostov Na Donu, Russia

[9] Lund, Div Urol Canc, Dept Translat Med, Kristianstad Cent Hosp, Malmo, Sweden

[10] Univ Aberdeen, Acad Urol Unit, Aberdeen, Scotland

[11] Erasmus MC, Dept Urol, Rotterdam, Netherlands

[12] Bayer HealthCare Pharmaceut Inc, Global Med Affairs Oncol, Real World Evidence, Whippany, NJ USA

[13] EORTC, Brussels, Belgium

[14] Univ Vita & Salute San Raffaele, Dept Urol, Milan, Italy

[15] Lund Univ, Dept Translat Med, Malmo, Sweden

来源：

EUROPEAN UROLOGY | 2021年 / 79卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

P0299

引用

页码：S428 / S429

页数：2

共 50 条

[21] PROGNOSTIC FACTORS IN PROSTATE-CANCER
IMAI, K
MATIDA, M
SUZUKI, T
KOBAYASHI, M
YAMANAKA, H
TOMARU, Y
[J]. AKTUELLE UROLOGIE, 1990, 21 : 112 - 114
[22] Prognostic factors in prostate and testis cancer
Van Brussel, JP
Mickisch, GHJ
[J]. BJU INTERNATIONAL, 1999, 83 (08) : 910 - 917
[23] Prognostic and predictive factors in prostate cancer
Hamdy, FC
[J]. CANCER TREATMENT REVIEWS, 2001, 27 (03) : 143 - 151
[24] Radical irradiation treatment in patients with prostate cancer: Results and prognostic factors
Peczkowski, T
Pilichowska, M
[J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 479 - 479
[25] Prognostic factors of prostate cancer patients at hospital Universiti Sains Malaysia
Chemay, Narjit Kaur
Naing, Nyi Nyi
Rahman, Mohd Nor Gohar
Bachok, Norsa'adah
[J]. INTERNATIONAL MEDICAL JOURNAL, 2008, 15 (03): : 225 - 231
[26] Prognostic risk factors and nomogram for Chinese American patients with prostate cancer
Xia, Yu
Ma, Bin-Bin
Liu, Xi
Huang, Tao
[J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (09) : 4080 - 4082
[27] Prostate specific antigen (PSA) as a diagnostic and prognostic marker of prostate cancer
Simon, Ronald
Kluth, Martina
Fischer, Kristine
Bonk, Sarah
Hube-Magg, Claudia
Hoflmayer, Doris
Lennartz, Maximilian
Lutz, Florian
Sauter, Guido
Buescheck, Franziska
Uhlig, Ria
Dum, David
Luebke, Andreas M.
Wittmer, Corinna
Jacobsen, Frank
Burandt, Eike
Steurer, Stefan
Minner, Waldemar Wilczakand Sarah
[J]. CANCER RESEARCH, 2019, 79 (13)
[28] Urinary microRNA as diagnostic and prognostic biomarkers for prostate cancer
Fredsoe, Jacob
Rasmussen, Anni K.
Thomsen, Anni R.
Mouritzen, Peter
Hoyer, Soren
Borre, Michael
Orntoft, Torben F.
Sorensen, Karina D.
[J]. CANCER RESEARCH, 2017, 77
[29] HISTOLOGY OF PROSTATE-CANCER - DIAGNOSTIC AND PROGNOSTIC FEATURES
GAETA, JF
[J]. CLINICAL ONCOLOGY MONOGRAPHS, 1983, 2 (02): : 301 - 318
[30] Identification of potential diagnostic and prognostic biomarkers for prostate cancer
Zhang, Qiang
Yin, Xiujuan
Pan, Zhiwei
Cao, Yingying
Han, Shaojie
Gao, Guojun
Gao, Zhiqin
Pan, Zhifang
Feng, Weiguo
[J]. ONCOLOGY LETTERS, 2019, 18 (04) : 4237 - 4245

← 1 2 3 4 5 →